Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Signature Genomic Laboratories and Agilent Technologies have signed a long-term supply agreement pursuant to which Agilent will supply custom oligonucleotide microarrays based on the Signature-designed SignatureChip Oligo Solution to Signature and its customers.
Subscribe to our email newsletter
The SignatureChip Oligo Solution (SignatureChipOS) is designed for the detection of chromosome abnormalities in individuals with mental retardation/developmental delay, autism and congenital anomalies. The 105,000-feature, 60-mer microarray covers over 150 syndromes, the subtelomeric and pericentromeric regions, and more than 500 genes in important developmental pathways.
Lisa Shaffer, president and CEO of Signature, said: “This supply agreement allows our Genoglyphix customers the opportunity to use high quality oligo arrays for research applications in their laboratories.”